1. The Patient-Reported Outcome (PRO) Consortium: filling measurement gaps for PRO endpoints to support labeling claims;Coons;Clin Pharmacol Ther,2011
2. Food and Drug Administration. Guidance for industry and FDA staff: qualification process for drug development tools. January 2014. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM230597.pdf. [Accessed February 2, 2016].
3. Clinical practice. Irritable bowel syndrome;Mayer;N Engl J Med,2008
4. Clinical trials in irritable bowel syndrome: a review;Ervin;Rev Recent Clin Trials,2013
5. Food and Drug Administration. Guidance for industry—patient-reported outcome measures: use in medical product development to support labeling claims. December 2009. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. [Accessed February 2, 2016].